Non-Current Assets

Deferred Tax Assets

Gilead Sciences Deferred Tax Assets decreased by 10.0% to $1.77B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 31.3%, from $2.57B to $1.77B.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryRisk
SignalContext dependent
VolatilityModerate
First reportedQ4 2016
Last reportedQ1 2026May 7, 2026

How to read this metric

An increase may indicate past operating losses or tax credits that provide a future buffer, while a decrease suggests the utilization of these benefits to offset tax liabilities.

Detailed definition

This represents the future tax benefits that the company expects to realize due to temporary differences between the fin...

Peer comparison

Standard across all industries; levels depend heavily on the company's historical profitability and tax jurisdiction profile.

Metric ID: non_current_assets_deferred_income_tax_assets_net

Historical Data

6 periods
 Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$2.38B$2.57B$2.72B$2.00B$1.96B$1.77B
QoQ Change+8.2%+5.8%-26.6%-1.7%-10.0%
YoY Change-17.4%-31.3%
Range$1.77B$2.72B
CAGR-21.1%
Avg YoY Growth-24.4%
Median YoY Growth-24.4%
Current Streak3 quarters decline

Frequently Asked Questions

What is Gilead Sciences's deferred tax assets?
Gilead Sciences (GILD) reported deferred tax assets of $1.77B in Q1 2026.
How has Gilead Sciences's deferred tax assets changed year-over-year?
Gilead Sciences's deferred tax assets decreased by 31.3% year-over-year, from $2.57B to $1.77B.
What does deferred tax assets mean?
Future tax savings the company expects to realize based on past financial activities.